FI886055A - Säännöstellysti vapauttava koostumus L2-faasiin liuotettua tai dispergoitua biologisesti aktiivista ainetta varten - Google Patents

Säännöstellysti vapauttava koostumus L2-faasiin liuotettua tai dispergoitua biologisesti aktiivista ainetta varten Download PDF

Info

Publication number
FI886055A
FI886055A FI886055A FI886055A FI886055A FI 886055 A FI886055 A FI 886055A FI 886055 A FI886055 A FI 886055A FI 886055 A FI886055 A FI 886055A FI 886055 A FI886055 A FI 886055A
Authority
FI
Finland
Prior art keywords
dispersed
phase
composition
active material
biologically active
Prior art date
Application number
FI886055A
Other languages
English (en)
Swedish (sv)
Other versions
FI97687C (fi
FI97687B (fi
Inventor
Sven Engstroem
Kaore Viktor Larsson
Bjoern Lindman
Original Assignee
Drilletten Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drilletten Ab filed Critical Drilletten Ab
Publication of FI886055A publication Critical patent/FI886055A/fi
Application granted granted Critical
Publication of FI97687B publication Critical patent/FI97687B/fi
Publication of FI97687C publication Critical patent/FI97687C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI886055A 1986-07-01 1988-12-30 Säännöstellysti vapauttava koostumus L2-faasiin liuotettua tai dispergoitua biologisesti aktiivista ainetta varten FI97687C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8602931 1986-07-01
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
SE8700279 1987-01-23
PCT/SE1987/000279 WO1988000059A1 (en) 1986-07-01 1987-06-12 A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase

Publications (3)

Publication Number Publication Date
FI886055A true FI886055A (fi) 1988-12-30
FI97687B FI97687B (fi) 1996-10-31
FI97687C FI97687C (fi) 1997-02-10

Family

ID=20364989

Family Applications (1)

Application Number Title Priority Date Filing Date
FI886055A FI97687C (fi) 1986-07-01 1988-12-30 Säännöstellysti vapauttava koostumus L2-faasiin liuotettua tai dispergoitua biologisesti aktiivista ainetta varten

Country Status (8)

Country Link
EP (1) EP0314689B1 (fi)
JP (1) JPH0759523B2 (fi)
CA (1) CA1296631C (fi)
DE (1) DE3778024D1 (fi)
DK (1) DK105888A (fi)
FI (1) FI97687C (fi)
SE (1) SE457693B (fi)
WO (1) WO1988000059A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
DE69025378T2 (de) * 1989-10-20 1996-06-20 Bioapatite Ab Implantatmaterialzusammensetzung, ihre Herstellung sowie ihre Verwendungen und daraus erhältliches Implantat
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
WO1992018147A1 (en) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
ES2098739T3 (es) 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
DE29824679U1 (de) 1997-01-30 2002-03-28 Novartis Ag, Basel Pharmazeutische Zusammensetzungen
BR9806238A (pt) * 1997-09-09 2005-07-12 Select Release L C Partìculas revestidas: processos de obtenção e uso
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
CN114145290A (zh) * 2021-06-02 2022-03-08 贵州省烟草科学研究院 高效长效昆虫性诱芯及其制作方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1052697A (en) * 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
SE8602931D0 (sv) 1986-07-01
FI97687C (fi) 1997-02-10
DE3778024D1 (fi) 1992-05-07
FI97687B (fi) 1996-10-31
SE457693B (sv) 1989-01-23
DK105888D0 (da) 1988-02-29
EP0314689A1 (en) 1989-05-10
JPH01503140A (ja) 1989-10-26
EP0314689B1 (en) 1992-04-01
DK105888A (da) 1988-02-29
JPH0759523B2 (ja) 1995-06-28
SE8602931L (sv) 1988-01-02
CA1296631C (en) 1992-03-03
WO1988000059A1 (en) 1988-01-14

Similar Documents

Publication Publication Date Title
FI886055A (fi) Säännöstellysti vapauttava koostumus L2-faasiin liuotettua tai dispergoitua biologisesti aktiivista ainetta varten
DK606086A (da) Transdermalt eller dermalt plaster til indgift af en kontrolleret maengde aktivt stof
KR880701115A (ko) 인공생체복합재료
GB2015464B (en) Method of encapsulating biologically active materials in lipid vesicles
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI850620A0 (fi) N-aryyli-3-aryyli-4,5-dihydro-1H-pyratsoli-1-karboksamidit, menetelmä niiden valmistamiseksi ja niitä sisältävät insektisidiseokset
FI890083A (fi) Menetelmä kasvi- tai eläinmateriaalien kuivaamiseksi
DK487687D0 (da) Midler egnede til human topisk applikation indeholdende en vaekstfaktor og/eller beslaegtede materialer
FI840923A0 (fi) Kristalliserad kolhydratmatris foer biologiskt aktiva substanser, saett att framstaella densamma sadess anvaendning
IT8323762A0 (it) Derivati glicosilati dell'insulina.
FI893959A0 (fi) Menetelmä partikkelien valmistamiseksi, jotka sisältävät biologisesti tuotetun aineen polymeerimateriaalimatriisissa
DK10687D0 (da) Paafoeringsmateriale til byggematerialer
FI945780A0 (fi) Uudet biologisesti aktiiviset eburnameniinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi
DK106685D0 (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
FI95914C (fi) Polypeptidijohdannaisia ja menetelmä niiden valmistamiseksi
HUT42510A (en) Process for preparing biologically active derivatives of humane gamma-interferone and pharmaceutical compositions containing such compounds
FI890484A (fi) Taimien kasvatuskennoston seinämämateriaali
GB2095260B (en) Ubstance and immunoactive composition biologically active substance process for preparing the s0
PT78571B (en) Process for preparing biologically active polypeptides and of pharmaceutical compositions containing the same
HU895680D0 (en) Insecticides containing as active substance derivatives of chrisanthemate
FI892144A0 (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
KR900700392A (ko) 초전도막 형성용 타아겟재
DK464686D0 (da) Praeparat med kontrolleret afgivelse af det aktive stof
HUT43316A (en) Herbicidal compositions comprising heterocyclic nitriferous compounds carrying aryl-carbomoyl groups as active substance and process for preparing the active substances
FI94417B (fi) Menetelmä farmakologisesti aktiivisten aminosteroidien valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
GB Transfer or assigment of application

Owner name: GS DEVELOPMENT AB

MM Patent lapsed

Owner name: GS DEVELOPMENT AB